CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces ...
EDX Medical has developed a new non-invasive prostate cancer test it hopes will transform diagnosis and detection of the disease. The purpose of the Cambridge, UK-based company’s test is to identify ...
This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018 ...
UK-based EDX Medical has developed a test designed to identify and characterise the early signs of pneumonia in critically ill hospitalised patients. EDX has partnered with the intensive care unit ...
‘Truly game-changing’ new test backed by Sir Chris Hoy ‘diagnoses prostate cancer with 96% accuracy’
Read on for a full list of prostate cancer symptoms you should get seen to by a GP SCIENTISTS have a developed a “game-changing” new “super test” that can diagnose prostate cancer with 96 per cent ...
Berkeley Varitronics Systems has partnered with EDX Wireless to provide compatibility between its YellowFin Mobile WiMAX analyzer and the EDX SignalPro software. As carriers build out WiMAX networks, ...
CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback